| ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD S Moore, E Alsop, I Lorenzini, A Starr, BE Rabichow, E Mendez, JL Levy, ... Acta neuropathologica 138, 49-65, 2019 | 69 | 2019 |
| Biomarker development for C9orf72 repeat expansion in ALS EF Mendez, R Sattler Brain research 1607, 26-35, 2015 | 37 | 2015 |
| Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients L Stertz, J Di Re, G Pei, GR Fries, E Mendez, S Li, L Smith-Callahan, ... Neuropsychopharmacology 46 (3), 673-682, 2021 | 33 | 2021 |
| Genome-wide correlation of DNA methylation and gene expression in postmortem brain tissues of opioid use disorder patients A Liu, Y Dai, EF Mendez, R Hu, GR Fries, KE Najera, S Jiang, TD Meyer, ... International Journal of Neuropsychopharmacology 24 (11), 879-891, 2021 | 32 | 2021 |
| A novel inhibitor of 5-lipoxygenase (5-LOX) prevents oxidative stress–induced cell death of retinal pigment epithelium (RPE) cells P Subramanian, EF Mendez, SP Becerra Investigative Ophthalmology & Visual Science 57 (11), 4581-4588, 2016 | 32 | 2016 |
| Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brain EF Mendez, H Wei, R Hu, L Stertz, GR Fries, X Wu, KE Najera, ... Molecular psychiatry 26 (12), 7803-7812, 2021 | 31 | 2021 |
| MicroRNA–mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations SL Grimm, EF Mendez, L Stertz, TD Meyer, GR Fries, T Gandhi, R Kanchi, ... Frontiers in Psychiatry 13, 1025346, 2023 | 11 | 2023 |
| A human stem cell-derived neuronal model of morphine exposure reflects brain dysregulation in opioid use disorder: Transcriptomic and epigenetic characterization of postmortem … EF Mendez, SL Grimm, L Stertz, D Gorski, SV Movva, K Najera, K Moriel, ... Frontiers in Psychiatry 14, 1070556, 2023 | 8 | 2023 |
| Postmortem-derived iPSC models in substance use disorders research EF Mendez, C Walss-Bass Neuropsychopharmacology 49, 349-350, 2024 | 1 | 2024 |
| Molecular Mechanisms of Opioid Use Disorder in Human Brain Models E Mendez | | 2024 |
| Cell-Type Specific Effects of Opioid Exposure in Human Brain E Mendez, H Wei, R Hu, L Stertz, GR Fries, X Wu, K Najera, K Moriel, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 444-444, 2021 | | 2021 |
| Differential Regulation of Angiogenic Gene Networks in Postmortem Brains of Opioid Use Disorder Subjects E Mendez, H Wei, L Stertz, G Fries, R Hu, X Wu, K Najera, K Moriel, ... Biological Psychiatry 89 (9), S317-S318, 2021 | | 2021 |
| Molecular Signatures of Cocaine Neurotoxicity in Human Brain Models E Mendez, L Stertz, G Fries, R Hu, T Meyer, Z Zhao, C Walss-Bass | | 2021 |
| 4141 Molecular Signatures of Cocaine Toxicity in Postmortem Human Brain and Neurons EF Mendez, L Stertz, G Fries, R Hu, T Meyer, Z Zhao, C Walss-Bass Journal of Clinical and Translational Science 4 (s1), 140-140, 2020 | | 2020 |
| ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD (vol 138, pg 49, 2019) S Moore, E Alsop, I Lorenzini, A Starr, BE Rabichow, E Mendez, JL Levy, ... ACTA NEUROPATHOLOGICA 138 (5), 883-884, 2019 | | 2019 |
| Identification of A Novel Inhibitor of 5‐Lipoxygenase P Subramanian, E Mendez, SP Becerra The FASEB Journal 29, LB107, 2015 | | 2015 |
